HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort

被引：0
|
作者：
Lin, Mingxi
Luo, Ting
Zhang, Hui
Yang, Wentao
Zhang, Jian
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Sichuan Univ, West China Hosp, Breast Dis Ctr, Chengdu, Sichuan, Peoples R China
[3] Northwestern Univ, Dept Prevent Med, Div Biostat, Chicago, IL USA
[4] Fudan Univ, Dept Breast & Urol Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1021
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The impact of the HER2-low status on conditional survival in patients with breast cancer
    Ma, Teng
    Liu, Changgen
    Ma, Tianyi
    Sun, Xinyi
    Cui, Jian
    Wang, Lulu
    Mao, Yan
    Wang, Haibo
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [32] Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
    Geukens, Tatjana
    De Schepper, Maxim
    Richard, Francois
    Maetens, Marion
    Van Baelen, Karen
    Mahdami, Amena
    Nguyen, Ha-Linh
    Isnaldi, Edoardo
    Leduc, Sophia
    Pabba, Anirudh
    Zels, Gitte
    Mertens, Freya
    Borght, Sara Vander
    Smeets, Ann
    Nevelsteen, Ines
    Punie, Kevin
    Neven, Patrick
    Wildiers, Hans
    van den Bogaert, Wouter
    Floris, Giuseppe
    Desmedt, Christine
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 152 - 160
  • [33] Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort
    Epaillard, N.
    Lusque, A.
    Jacot, W.
    Mailliez, A.
    Bachelot, T.
    Arnedos, M.
    Le Du, F.
    Brain, E.
    Ferrero, J. M.
    Massard, V.
    Desmoulins, I.
    Mouret-Reynier, M. A.
    Levy, C.
    Goncalves, A.
    Leheurteur, M.
    Petit, T.
    Filleron, T.
    Bosquet, L.
    Pistilli, B.
    Frenel, J. S.
    ESMO OPEN, 2024, 9 (05)
  • [34] Discordance in estrogen receptor, progesterone receptor and HER-2/neu status between primary and metastatic breast cancer: A systematic review
    Yeung, I. C.
    Clemons, M.
    Haggar, F.
    Addison, C.
    Hutton, B.
    Kuchuk, I.
    Zhu, X.
    Mazzarello, S.
    Arnaout, A.
    CANCER RESEARCH, 2013, 73
  • [35] DISCORDANCE OF HORMONE RECEPTOR AND HER2 STATUS BETWEEN PRIMARY AND RECURRENT BREAST CANCER: NEW TREATMENT STRATEGY FOR PREDICTING OUTCOME OF PATIENTS WITH BREAST CANCER
    Shiino, Sho
    Kinoshita, Takayuki
    Taruno, Kanae
    Jimbo, Kenjiro
    Asaga, Souta
    Hojo, Takashi
    Yoshida, Masayuki
    Tsuda, Hitoshi
    BREAST, 2013, 22 : S58 - S58
  • [36] The clinicopathological and prognostic significance of HER2-low breast cancer: A comparative analysis between HER2-low and HER2-zero subtypes
    Nishimura, Reiki
    Fujiki, Yoshitaka
    Taira, Tetsuhiko
    Miyaki, Toshiko
    Kanemitsu, Shuichi
    Yotsumoto, Daisuke
    Teraoka, Megumi
    Kawano, Junko
    Gondo, Naomi
    Mitsueda, Reiko
    Baba, Shinichi
    Ohi, Yasuyo
    Rai, Yoshiaki
    Sagara, Yoshiaki
    Sagara, Yasuaki
    CANCER RESEARCH, 2024, 84 (09)
  • [37] The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes
    Nishimura, Reiki
    Fujiki, Yoshitaka
    Taira, Tetsuhiko
    Miyaki, Toshiko
    Kanemitsu, Shuichi
    Yotsumoto, Daisuke
    Teraoka, Megumi
    Kawano, Junko
    Gondo, Naomi
    Mitsueda, Reiko
    Baba, Shinichi
    Ohi, Yasuyo
    Rai, Yoshiaki
    Sagara, Yoshiaki
    Sagara, Yasuaki
    CLINICAL BREAST CANCER, 2024, 24 (05) : 431 - 438
  • [38] Comparison of ER, PR, HER2 Status in Metastatic Breast Carcinomas Between Cytological and Surgical Specimens, in the HER2-low Era
    Nevels, Anna
    Niu, Shuo
    Hou, Yanjun
    LABORATORY INVESTIGATION, 2024, 104 (03) : S449 - S450
  • [39] Discordance in estrogen, progesterone and HER2/neu status between primary and recurrent breast tumours: A systematic review
    Yeung, I.
    Clemons, M.
    Hutton, B.
    Haggar, F.
    Addison, C. L.
    Kuchuk, I.
    Zhu, X.
    Mazzarello, S.
    Arnaout, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S58 - S58
  • [40] Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer
    Yi, Zongbi
    Feng, Kaixiang
    Lv, Dan
    Guan, Yanfang
    Shao, Youcheng
    Ma, Fei
    Xu, Binghe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
12345